Long term alterations of growth after antenatal steroids in preterm twin pregnancies.


Journal

Journal of perinatal medicine
ISSN: 1619-3997
Titre abrégé: J Perinat Med
Pays: Germany
ID NLM: 0361031

Informations de publication

Date de publication:
23 Feb 2021
Historique:
received: 11 05 2020
accepted: 11 09 2020
pubmed: 4 10 2020
medline: 29 10 2021
entrez: 3 10 2020
Statut: epublish

Résumé

To compare the long-term effects of antenatal betamethasone (ANS, ≤16 mg, =24 mg and >24 mg) in twins on infant and childhood growth. A retrospective cohort follow up study among 198 twins after ANS including three time points: U1 first neonatal examination after birth and in the neonatal period; U7 examination from the 21st to the 24th month of life and U9 examination from the 60th to the 64th month of life using data from copies of the children's examination booklets. Inclusion criteria are twin pregnancies with preterm labor, cervical shortening, preterm premature rupture of membranes, or vaginal bleeding, and exposure to ANS between 23+5 and 33+6 weeks. Outcome measures are dosage-dependent and sex-specific effects of ANS on growth (body weight, body length, head circumference, body mass index and ponderal index) up to 5.3 years. Overall, 99 live-born twin pairs were included. Negative effects of ANS on fetal growth persisted beyond birth, altered infant and childhood growth, independent of possible confounding factors. Overall weight percentile significantly decreased between infancy and early childhood by 18.8%. Birth weight percentiles significantly changed in a dose dependent and sex specific manner, most obviously in female-female and mixed pairs. The ponderal index significantly decreased up to 42.9%, BMI index increased by up to 33.8%. ANS results in long-term alterations in infant and childhood growth. Changes between infancy and early childhood in ponderal mass index and BMI, independent of dose or twin pair structure, might indicate an ANS associated increased risk for later life disease. First-time report on long-term ANS administration growth effects in twin pregnancies, showing persisting alterations beyond birth in infant and childhood growth up to 5.3 years as potential indicator of later life disease risk.

Identifiants

pubmed: 33010142
doi: 10.1515/jpm-2020-0204
pii: jpm-2020-0204
doi:

Substances chimiques

Glucocorticoids 0
Betamethasone 9842X06Q6M

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

127-137

Informations de copyright

© 2020 Thorsten Braun et al., published by De Gruyter, Berlin/Boston.

Références

Roberts, D, Dalziel, S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;3:CD004454. https://doi.org/10.1002/14651858.CD004454.pub2.
Justus, G, Sloboda, DM, Henrich, W, Plagemann, A, Dudenhausen, JW, Braun, T. Avoiding the prenatal programming effects of glucocorticoids: are there alternative treatments for the induction of antenatal lung maturation?. J Perinat Med 2015;43:503–23. https://doi.org/10.1515/jpm-2014-0295.
Braun, T, Sloboda, DM, Tutschek, B, Harder, T, Challis, JR, Dudenhausen, JW, et al. Fetal and neonatal outcomes after term and preterm delivery following betamethasone administration. Int J Gynaecol Obstet 2015;130:64–9. https://doi.org/10.1016/j.ijgo.2015.01.013.
Braun, T, Weichert, A, Gil, HC, Sloboda, DM, Tutschek, B, Harder, T, et al. Fetal and neonatal outcomes after term and preterm delivery following betamethasone administration in twin pregnancies. Int J Gynaecol Obstet 2016;134:329–35. https://doi.org/10.1016/j.ijgo.2016.02.016.
Braun, T, Challis, JR, Newnham, JP, Sloboda, DM. Early-life glucocorticoid exposure: the hypothalamic-pituitary-adrenal axis, placental function, and long-term disease risk. Endocr Rev 2013;34:885–916. https://doi.org/10.1210/er.2013-1012.
Moisiadis, VG, Matthews, SG. Glucocorticoids and fetal programming part 1: outcomes. Nat Rev Endocrinol 2014;10:391–402. https://doi.org/10.1038/nrendo.2014.73.
McKinlay, CJ, Dalziel, SR, Harding, JE. Antenatal glucocorticoids: where are we after forty years?. J Dev Orig Health Dis 2015;6:127–42. https://doi.org/10.1017/s2040174414000579.
Hrabalkova, L, Takahashi, T, Kemp, MW, Stock, SJ. Antenatal corticosteroids for fetal lung maturity − too much of a good thing?. Curr Pharmaceut Des 2019;25:593–600. https://doi.org/10.2174/1381612825666190326143814.
Murphy, DJ, Caukwell, S, Joels, LA, Wardle, P. Cohort study of the neonatal outcome of twin pregnancies that were treated with prophylactic or rescue antenatal corticosteroids. Am J Obstet Gynecol 2002;187:483–8. https://doi.org/10.1067/mob.2002.123891.
Turrentine, MA, Wilson, PD, Wilkins, IA. A retrospective analysis of the effect of antenatal steroid administration on the incidence of respiratory distress syndrome in preterm twin pregnancies. Am J Perinatol 1996;13:351–4. https://doi.org/10.1055/s-2007-994355.
Blickstein, I, Shinwell, ES, Lusky, A, Reichman, B, Israel Neonatal, N. Plurality-dependent risk of respiratory distress syndrome among very-low-birth-weight infants and antepartum corticosteroid treatment. Am J Obstet Gynecol 2005;192:360–4. https://doi.org/10.1016/j.ajog.2004.10.604.
Crowley, P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 1996:CD000065. https://doi.org/10.1002/14651858.CD000065.
Ballabh, P, Lo, ES, Kumari, J, Cooper, TB, Zervoudakis, I, Auld, PA, et al. Pharmacokinetics of betamethasone in twin and singleton pregnancy. Clin Pharmacol Ther 2002;71:39–45. https://doi.org/10.1067/mcp.2002.120250.
Gyamfi, C, Mele, L, Wapner, RJ, Spong, CY, Peaceman, A, Sorokin, Y, et al. The effect of plurality and obesity on betamethasone concentrations in women at risk for preterm delivery. Am J Obstet Gynecol 2010;203:219 e1–5. https://doi.org/10.1016/j.ajog.2010.04.047.
Suhag, A, Berghella, V. What’s new in the multiple gestations literature?. J Perinat Med 2018;46:823–4. https://doi.org/10.1515/jpm-2018-0304.
Bührer C. Perinatalerhebung 2013. Geburtshilfe Frauenheilkd 2016;76:A4https://doi.org/10.1055/s-0036-1571401.
Gräfe, D. Ped(z) Kinderarzt rechner; 2019. Available from: https://www.pedz.de/de/bmi.html.
Kromeyer-Hauschild, K, Wabitsch, M, Kunze, D, Geller, F, Geiß, HC, Hesse, V, et al. Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001;149:807–18. https://doi.org/10.1007/s001120170107.
Heese, V, Schnabel, O, Judis, E, Cammann, H, Hinkel, J, Weissenborn, J. Longitudinal study of the growth of German children aged 0 to 6 years: Part 2. Monatsschr Kinderheilkd 2016;164:892–912 https://doi.org/10.1007/s00112-016-0068-0.
Heese, V, Schnabel, O, Judis, E, Cammann, H, Hinkel, J, Weissenborn, J. Longitudinal study of the current growth of German children aged 0 to 6 years: part 1. Monatsschr Kinderheilkd 2016;164:478–96 https://doi.org/10.1007/s00112-016-0067-1.
Heese, V, Schnabel, O, Judis, E, Cammann, H, Hinkel, J, Weissenborn, J. Longitudinal study of the current growth of German children aged 0 to 6 years: part 3. Monatsschr Kinderheilkd 2017;165:148–70 https://doi.org/10.1007/s00112-016-0069-z.
Braegger, C, Janni, O, Konrad, D, Molinari, L. Neue Wachstumskurven für die Schweiz. Paediatrica 2011;22:9–11.
Ashley-Martin, J, Ensenauer, R, Maguire, B, Kuhle, S. Predicting cardiometabolic markers in children using tri-ponderal mass index: a cross-sectional study. Arch Dis Child 2019;104:577–82. https://doi.org/10.1136/archdischild-2018-316028.
Braun, T, Husar, A, Challis, JR, Dudenhausen, JW, Henrich, W, Plagemann, A, et al. Growth restricting effects of a single course of antenatal betamethasone treatment and the role of human placental lactogen. Placenta 2013;34:407–15. https://doi.org/10.1016/j.placenta.2013.02.002.
Liggins Institute. The University of Auckland New Zealand. Antenatal corticosteroids given to women prior to birth to improve fetal, infant, child and adult health. N Z Aust Clin Pract Guidel 2015.
Braun, F, Hardt, AK, Ehrlich, L, Sloboda, DM, Challis, JRG, Plagemann, A, et al. Sex-specific and lasting effects of a single course of antenatal betamethasone treatment on human placental 11beta-HSD2. Placenta 2018;69:9–19. https://doi.org/10.1016/j.placenta.2018.07.007.
Challis, J, Newnham, J, Petraglia, F, Yeganegi, M, Bocking, A. Fetal sex and preterm birth. Placenta 2013;34:95–9. https://doi.org/10.1016/j.placenta.2012.11.007.
Peterson, CM, Su, H, Thomas, DM, Heo, M, Golnabi, AH, Pietrobelli, A, et al. Tri-ponderal mass index vs body mass index in estimating body fat during adolescence. JAMA Pediatr 2017;171:629–36. https://doi.org/10.1001/jamapediatrics.2017.0460.
Ong, KK, Loos, RJ. Rapid infancy weight gain and subsequent obesity: systematic reviews and hopeful suggestions. Acta Paediatr 2006;95:904–8. https://doi.org/10.1080/08035250600719754.
Ong, KK, Emmett, P, Northstone, K, Golding, J, Rogers, I, Ness, AR, et al. Infancy weight gain predicts childhood body fat and age at menarche in girls. J Clin Endocrinol Metab 2009;94:1527–32. https://doi.org/10.1210/jc.2008-2489.
Howe, LD, Tilling, K, Benfield, L, Logue, J, Sattar, N, Ness, AR, et al. Changes in ponderal index and body mass index across childhood and their associations with fat mass and cardiovascular risk factors at age 15. PLoS One 2010;5: e15186. https://doi.org/10.1371/journal.pone.0015186.
Carrascosa, A, Yeste, D, Moreno-Galdo, A, Gussinye, M, Ferrandez, A, Clemente, M, et al. [Body mass index and tri-ponderal mass index of 1,453 healthy non-obese, non-undernourished millennial children. The Barcelona longitudinal growth study]. An Pediatr 2018;89:137–43. https://doi.org/10.1016/j.anpede.2018.01.006.
van Dommelen, P, de Gunst, M, van der Vaart, A, van Buuren, S, Boomsma, D. Growth references for height, weight and body mass index of twins aged 0–2.5 years. Acta Paediatr 2008;97:1099–104. https://doi.org/10.1111/j.1651-2227.2008.00853.x.

Auteurs

Thorsten Braun (T)

Clinic of Obstetrics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Division of Experimental Obstetrics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Vivien Filleböck (V)

Clinic of Obstetrics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Boris Metze (B)

Clinic of Neonatology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Christoph Bührer (C)

Clinic of Neonatology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Andreas Plagemann (A)

Division of Experimental Obstetrics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Wolfgang Henrich (W)

Clinic of Obstetrics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH